These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11181667)

  • 41. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.
    Einaudi S; Bertorello N; Masera N; Farinasso L; Barisone E; Rizzari C; Corrias A; Villa A; Riva F; Saracco P; Pastore G
    Pediatr Blood Cancer; 2008 Mar; 50(3):537-41. PubMed ID: 17828747
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)].
    Riehm H; Reiter A; Schrappe M; Berthold F; Dopfer R; Gerein V; Ludwig R; Ritter J; Stollmann B; Henze G
    Klin Padiatr; 1987; 199(3):151-60. PubMed ID: 3306129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy.
    Nachman JB; Sather HN; Sensel MG; Trigg ME; Cherlow JM; Lukens JN; Wolff L; Uckun FM; Gaynon PS
    N Engl J Med; 1998 Jun; 338(23):1663-71. PubMed ID: 9614257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful in vitro purging of leukemic blasts from marrow by cortivazol, a pyrazolosteroid: a preclinical study for autologous transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
    Juneja HS; Harvey WH; Brasher WK; Thompson EB
    Leukemia; 1995 Oct; 9(10):1771-8. PubMed ID: 7564524
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow.
    Basso G; Veltroni M; Valsecchi MG; Dworzak MN; Ratei R; Silvestri D; Benetello A; Buldini B; Maglia O; Masera G; Conter V; Arico M; Biondi A; Gaipa G
    J Clin Oncol; 2009 Nov; 27(31):5168-74. PubMed ID: 19805690
    [TBL] [Abstract][Full Text] [Related]  

  • 46. XIAP expression is post-transcriptionally upregulated in childhood ALL and is associated with glucocorticoid response in T-cell ALL.
    Hundsdoerfer P; Dietrich I; Schmelz K; Eckert C; Henze G
    Pediatr Blood Cancer; 2010 Aug; 55(2):260-6. PubMed ID: 20582956
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemia.
    Wolfrom C; Hartmann R; Fengler R; Brühmüller S; Ingwersen A; Henze G
    J Clin Oncol; 1993 May; 11(5):827-33. PubMed ID: 8487046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics and pharmacodynamics of oral etoposide in children with relapsed or refractory acute lymphoblastic leukemia.
    Edick MJ; Gajjar A; Mahmoud HH; van de Poll ME; Harrison PL; Panetta JC; Rivera GK; Ribeiro RC; Sandlund JT; Boyett JM; Pui CH; Relling MV
    J Clin Oncol; 2003 Apr; 21(7):1340-6. PubMed ID: 12663724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Short-term effects of prednisolone and dexamethasone on circulating concentrations of leptin and sex hormone-binding globulin in children being treated for acute lymphoblastic leukaemia.
    Wallace AM; Tucker P; Williams DM; Hughes IA; Ahmed SF
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):770-6. PubMed ID: 12780755
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Daunorubicin-induced cell kill with 1-hour versus 24-hour infusions: a randomized comparison in children with newly diagnosed acute lymphoblastic leukemia.
    Escherich G; Göbel U; Jorch N; Spaar HJ; Janka-Schaub GE
    Klin Padiatr; 2007; 219(3):134-8. PubMed ID: 17525906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia.
    Rea D; Legros L; Raffoux E; Thomas X; Turlure P; Maury S; Dupriez B; Pigneux A; Choufi B; Reman O; Stéphane D; Royer B; Vigier M; Ojeda-Uribe M; Recher C; Dombret H; Huguet F; Rousselot P; ;
    Leukemia; 2006 Mar; 20(3):400-3. PubMed ID: 16437142
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: a Childrens Cancer Group report.
    Gilchrist GS; Tubergen DG; Sather HN; Coccia PF; O'Brien RT; Waskerwitz MJ; Hammond GD
    J Clin Oncol; 1994 Dec; 12(12):2594-600. PubMed ID: 7989934
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
    Mattano LA; Sather HN; Trigg ME; Nachman JB
    J Clin Oncol; 2000 Sep; 18(18):3262-72. PubMed ID: 10986059
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glucocorticoids in the treatment of children with acute lymphoblastic leukemia and hodgkin's disease: a pilot study on the adverse psychological reactions and possible associations with neurobiological, endocrine, and genetic markers.
    Felder-Puig R; Scherzer C; Baumgartner M; Ortner M; Aschenbrenner C; Bieglmayer C; Voigtländer T; Panzer-Grümayer ER; Tissing WJ; Koper JW; Steinberger K; Nasel C; Gadner H; Topf R; Dworzak M
    Clin Cancer Res; 2007 Dec; 13(23):7093-100. PubMed ID: 18056188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resistance to glucocorticoids in childhood acute lymphoblastic leukemia: impact of relationship between ex vivo sensitivity and in vivo concentration on risk factor analysis.
    Styczynski J; Koltan A; Wysocki M
    Neoplasma; 2006; 53(2):168-73. PubMed ID: 16575474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential antileukemic activity of prednisolone and dexamethasone in freshly isolated leukemic cells.
    Mihál V; Hajdúch M; Nosková V; Feketová G; Jess K; Gojová L; Kaspárek I; Starý J; Blazek B; Pospísilová D; Novák Z
    Adv Exp Med Biol; 1999; 457():461-71. PubMed ID: 10500823
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apoptosis and acute lymphocytic leukemia in children.
    Schuler D; Szende B
    Ann N Y Acad Sci; 1997 Sep; 824():28-37. PubMed ID: 9382453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of dexamethasone and prednisone on sleep in children with acute lymphoblastic leukemia.
    Daniel LC; Li Y; Kloss JD; Reilly AF; Barakat LP
    Support Care Cancer; 2016 Sep; 24(9):3897-906. PubMed ID: 27108263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Corticosteroid-induced glaucoma in pediatric patients with hematological malignancies.
    Sugiyama M; Terashita Y; Hara K; Cho Y; Iguchi A; Chin S; Manabe A
    Pediatr Blood Cancer; 2019 Dec; 66(12):e27977. PubMed ID: 31489974
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Response of recurrent acute lymphoblastic leukemia to glucocorticoids: serial studies of receptor content, in vivo cytokinetic changes and clinical responses.
    Pui CH; Costlow ME; Dahl GV; Rivera G; Murphy SB
    Leuk Res; 1983; 7(6):747-53. PubMed ID: 6582341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.